MYD88 and metabolic dysfunction-associated steatotic liver disease: Activation of the transcriptional factor NF-κB, a downstream target of TLR-MyD88 signaling, is crucial to the inflammatory response in immune cells and is key to the development of NAFLD [11, 38].